【Helius Medical Technologies-Product PoNS】Helius Announces Third Collaboration to Implement Clinical Experience Programs with PoNS? Treatment in the United States

3^rd January 2019- Helius Medical Technologies, Inc. issued an announcement, which
is summarized as follows：

Helius Medical Technologies, Inc. announced that its wholly
owned subsidiary, NeuroHabilitation Corporation, entered into an agreement in
December 2018 to collaborate with Oregon Health & Science University (OHSU)
in Portland, Oregon for launch of its third Clinical Experience Program (CEP)
for PoNS^?.

“Helius is excited to announce this important collaboration
with Oregon Health & Science University and we’re pleased by the progress
that we made with respect to the development of our Clinical Experience Programs
– an important activity that we are pursuing in advance of U.S. regulatory
clearance,” said Philippe Deschamps, Helius’ Chief Executive Officer. “We look
forward to gaining more real-world experience in the clinical setting and
generate evidence demonstrating the health outcomes that can be achieved with
our innovative PoNS Treatment.”

Mr. Deschamps continued: “We expect to begin patient
recruitment and enrollment at the OHSU Center for Regenerative Medicine in the
first quarter of 2019, following site activation and training.”

The original website link：

https://heliusmedical.com/index.php/newsroom/news-release/2019/259-